comparemela.com

Plus Therapeutics (NASDAQ:PSTV – Get Rating) had its target price lowered by Maxim Group from $30.00 to $12.00 in a report issued on Wednesday, The Fly reports. Separately, HC Wainwright reissued a buy rating and set a $52.50 price target on shares of Plus Therapeutics in a report on Friday, April 21st. Plus Therapeutics Stock […]

Related Keywords

,Millennium Management ,Therapeutics Inc ,Maxim Group ,Vanguard Group Inc ,Schonfeld Strategic Advisors ,Renaissance Technologies ,Plus Therapeutics ,Get Rating ,Strategic Advisors ,Vanguard Group ,Plus Therapeutics Daily ,Nasdaq Pstv ,Pstv ,Medical ,Lower Price Target ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.